Last $29.84 USD
Change Today +0.35 / 1.19%
Volume 21.1M
PFE On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
SIX Swiss Ex
Stockholm
London
Sao Paulo
Bogota
As of 8:04 PM 10/30/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sally Susman

Executive Vice President of Policy External Affairs and Communications, Pfizer Inc.
AgeTotal Calculated CompensationThis person is connected to 34 board members in 3 different organizations across 4 different industries.

See Board Relationships
52--

Background*

Ms. Sally Susman has been an Executive Vice President of Policy, External Affairs and Communications at Pfizer Inc since December 2010. Ms. Susman also heads the Pfizer's corporate responsibility group and plays a key role in shaping policy initiatives. She served as Senior Vice President of Policy, External Affairs & Communications, Chief Communications Officer and Head of Corporate Communications at Pfizer Inc. from February 2008 to December 2010. Prior to joining ...

Read Full Background

Corporate Headquarters*

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships*

Trustee of Equity Office Properties Trust - General Partner
2005-Present
Trustee, Member of Committee of Independent Trustees and Member of Compensation Committee
2013-Present
Non-Executive Director and Member of Nomination & Governance Committee

Education*

BA
Connecticut College
Unknown/Other Education
The London School of Economics and Political Science

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE:US $29.84 USD +0.35

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.